5don MSN
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
In May, President Trump signed an executive order imposing Most-Favored-Nation (MFN) price caps on pharmaceuticals. While the ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
5don MSN
WATCH: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals
Health Secretary Robert F. Kennedy Jr. and Medicare Administrator Dr. Mehmet Oz are scheduled to hold a news briefing ...
Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...
It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...
Chester B. Good, M.D., MPH, senior medical director for value-based pharmacy at UPMC Health Plan, shared a personal story about his brother-in-law who died from complications before receiving the ...
Panelists discuss how CNS-active EGFR TKIs are improving intracranial outcomes and influencing treatment selection in NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback